Marine Pharmaceutical Market is valued at USD 1679.2 Million in 2021 and is expected to reach USD 2771.4 Million By 2028 with a CAGR of 7.42% over the forecast period.
Pharmaceutical properties coupled with increasing licensing agreements are likely to grow the marine pharmaceutical market.
Scope of Global Marine Pharmaceutical Market Report–
Marine pharmaceuticals are the drugs and pharmaceutical products derived from marine organisms. As 70% of the earth is covered by oceans and it has a large biodiversity and various minerals and vitamins which may help in the treatment of various disorders. There are various pharmaceutical products derived from marine life includes cod liver oil, chitin, agar, and others. Marine algae are also rich in various anti-inflammatory properties and minerals which help in the treatment of inflammatory diseases. Marine pharmaceuticals are natural products with reduced side effects and increased efficiency on a large scale.
Marine Pharmaceutical Market report is segmented on chemicals, marine group, application, and by regional & country level. Based upon chemicals, the marine pharmaceutical market is segmented into phenols, strigolactones, ethers, steroids, and peptides. On the basis of the marine group, the market is segmented into marine algae, marine microorganisms, and marine invertebrates. Based upon application, the marine pharmaceutical market is classified into Oncology, Cardiovascular, Anti-infective, and others.
The regions covered in this Marine Pharmaceutical market report are North America, Europe, Asia-Pacific, and the Rest of the World. On the basis of country level, the market of the Marine Pharmaceutical market is subdivided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Marine Pharmaceutical Companies
Some major key players for Marine Pharmaceutical market like,
Marine Pharmaceutical Market Segmentation
By Chemicals-
By Marine Group-
By Application-
Some major key players for the Marine Pharmaceutical Market are Genzyme, Abbott Laboratories, Marine Polymer Technologies, Inc., Bayer Innovation, Pharma Marine USA, Takeda Oncology’s Millennium, LLC, Xenome Limited among others.
Pharmaceutical properties coupled with increasing licensing agreements are the key factor that helps Marine Pharmaceutical Market to grow.
Over the period of time, there has been increasing in the licensing agreements among market players which have to provide excess to the improved and advanced technology for each other which help in the development of various pharmaceutical products. Furthermore, various anti-inflammatory, antibacterial, and other properties have fueled the growth of the marine pharmaceuticals market. Moreover, increased exploration of marine life and marine-derived substances has also increased the demand for marine pharmaceuticals. Increased prevalence of chronic disorders and increased technological advancement are further expected to contribute to the growth of the marine pharmaceutical market over the forecast period. Increased research and development activities are further expected to create ample opportunities in the marine pharmaceutical market. However, the high cost of these drugs is expected to hamper the growth of the marine pharmaceutical market in the near future.
North America is expected to dominate the Marine Pharmaceutical Market.
North America is expected to account for the major market share over the forecast period owing to the presence of developed economies such as India, China, and others. The high disposable income and developed healthcare facilities coupled with increased adoption of advanced technology for the production of marine pharmaceuticals.
Europe is expected to account for the second-largest market share owing to the presence of advanced technology coupled with an increase in research and development activities on large scale are expected to support the growth of the marine pharmaceutical market.
The Asia Pacific is expected to develop rapidly over the forecast period owing to the presence of developing economies such as India, China, and others. Furthermore, increasing disposable income coupled with the increased prevalence of chronic disorders and infectious diseases are expected to anticipate the growth of the marine pharmaceutical market over the forecast period. Africa, Latin America, and the Middle East are expected to develop at a considerable rate in the near future.
Report Analysis |
Details |
Historical data |
2015 - 2020 |
Forecast Period |
2021 - 2027 |
Market Size in 2020: |
USD 1679.2 Million |
Base year considered |
2020 |
Forecast Period CAGR %: |
7.42% |
Market Size Expected in 2027: |
USD 2771.4 Million |
Tables, Charts & Figures: |
175 |
Pages |
200 |
Marine Pharmaceuticals Manufacturers |
Genzyme, Abbott Laboratories, Marine Polymer Technologies, Inc., Bayer Innovation, Pharma Marine USA, Takeda Oncology’s Millennium, LLC, Xenome Limited |
Segments Covered |
By Chemicals, By Marine Group, By Application |
Regional Analysis |
North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa |
Key Benefits for Marine Pharmaceutical Market Reports –
On Special Requirement Marine Pharmaceutical Market Report is also available for the below Regions and Country:
North America
Europe
Asia-Pacific
Latin America
The Middle East and Africa
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®